<p>随着我们进入 2026 年，亚洲市场正在应对一个复杂的环境，主要经济体如中国和日本的表现参差不齐，制造业和科技行业略有增长，但经济不确定性依然存在。在这种环境下，识别被低估的股票需要对内在价值估计保持敏锐的关注，因为投资者在波动的市场条件中寻求潜在价值的机会。</p>
<h3>基于现金流的亚洲十大被低估股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>当前价格</strong></td>
<td><strong>公允价值（估计）</strong></td>
<td><strong>折扣（估计）</strong></td>
</tr>
<tr>
<td>浙江世纪华通集团有限公司 (SZSE:002602)</td>
<td>CN¥19.06</td>
<td>CN¥37.98</td>
<td>49.8%</td>
</tr>
<tr>
<td>厦门特宝生物科技 (SHSE:688278)</td>
<td>CN¥82.07</td>
<td>CN¥161.67</td>
<td>49.2%</td>
</tr>
<tr>
<td>药明 XDC 开曼 (SEHK:2268)</td>
<td>HK$68.40</td>
<td>HK$135.71</td>
<td>49.6%</td>
</tr>
<tr>
<td>PeptiDream (TSE:4587)</td>
<td>¥1747.00</td>
<td>¥3449.68</td>
<td>49.4%</td>
</tr>
<tr>
<td>Mobvista (SEHK:1860)</td>
<td>HK$15.44</td>
<td>HK$30.63</td>
<td>49.6%</td>
</tr>
<tr>
<td>美图 (SEHK:1357)</td>
<td>HK$7.42</td>
<td>HK$14.63</td>
<td>49.3%</td>
</tr>
<tr>
<td>CURVES HOLDINGS (TSE:7085)</td>
<td>¥792.00</td>
<td>¥1577.34</td>
<td>49.8%</td>
</tr>
<tr>
<td>Contec.Co.Ltd (KOSDAQ:A451760)</td>
<td>₩14490.00</td>
<td>₩28785.36</td>
<td>49.7%</td>
</tr>
<tr>
<td>ASE 科技控股 (TWSE:3711)</td>
<td>NT$273.50</td>
<td>NT$538.87</td>
<td>49.2%</td>
</tr>
<tr>
<td>Aidma Holdings (TSE:7373)</td>
<td>¥3160.00</td>
<td>¥6305.80</td>
<td>49.9%</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们基于现金流的 259 只被低估的亚洲股票的完整列表。</p>
<p>以下是筛选器中一些选择的预览。</p>
<h2>Morimatsu International Holdings (SEHK:2155)</h2>
<p><strong>概述：</strong> Morimatsu International Holdings Company Limited 从事化学反应、生物反应和聚合的核心设备和工艺系统的设计、制造、安装、运营和维护，市值为 HK$128.3 亿。</p>
<p><strong>运营：</strong> 该公司主要通过销售综合压力设备产生收入，金额为 CN¥61.6 亿。</p>
<p><strong>公允价值折扣估计：</strong> 48.6%</p>
<p>Morimatsu International Holdings 似乎被低估，当前交易价格为 HK$10.3，估计公允价值为 HK$20.05，基于折现现金流分析显示其低于公允价值 48.6%。尽管最近内部人士大量抛售以及一位关键董事会成员的不幸去世影响了合规性，但该公司显示出强大的潜力，预计年收益将显著增长 23%，超过香港市场平均增长率 12%。</p>
<ul>
<li>根据我们最近的增长报告，Morimatsu International Holdings 的财务表现似乎有可能超过当前水平。</li>
<li>在这份财务健康报告中，获取我们对 Morimatsu International Holdings 股票分析的全面见解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/743c07aa-1181-4742-99ba-a9c4f184b71b/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/743c07aa-1181-4742-99ba-a9c4f184b71b/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>SEHK:2155 截至 2026 年 1 月的折现现金流</p>
<h2>天齐锂业 (SZSE:002466)</h2>
<p><strong>概述：</strong> 天齐锂业股份有限公司从事锂及锂化合物的投资、生产、加工、提取和销售，业务遍及澳大利亚、智利和中国，市值为 CN¥944 亿。</p>
<p><strong>运营：</strong> 天齐锂业主要通过在澳大利亚、智利和中国生产和销售锂、锂浓缩物和特种锂化合物来产生收入。</p>
<p><strong>公允价值折扣估计：</strong> 42.8%</p>
<p>天齐锂业的交易价格为 CN¥58.62，显著低于其估计公允价值 CN¥102.5，基于折现现金流分析显示出显著的低估。尽管最近高管变动和股价波动，该公司在截至 2025 年 9 月的九个月内报告了净收入的扭转，预计将在三年内实现盈利。收入增长预计将超过中国市场平均水平，增强其作为亚洲被低估投资机会的吸引力。</p>
<ul>
<li>我们最近的增长报告提供了对天齐锂业商业前景的乐观预测。</li>
<li>在我们的报告中，仔细查看天齐锂业的资产负债表健康状况。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b0536878-1d44-4c90-bcd8-5d8b4e9d724a/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b0536878-1d44-4c90-bcd8-5d8b4e9d724a/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>SZSE:002466 截至 2026 年 1 月的折现现金流</p>
<h2>Innodisk (TPEX:5289)</h2>
<p><strong>概述：</strong> Innodisk Corporation 从事工业嵌入式存储设备的研究、开发、制造和销售，业务遍及多个国际市场，市值为 NT$615 亿。</p>
<p><strong>运营：</strong> 该公司通过其专注于各种工业存储设备研发的部门产生收入，金额为 NT$116.8 亿。</p>
<p><strong>公允价值折扣估计：</strong> 22.5%</p>
<p>Innodisk 的交易价格为 NT$645，低于其估计公允价值 NT$832.02，基于现金流分析显示出显著的低估。该公司报告了 2025 年第三季度强劲的收益增长，净收入达到 NT$643.04 百万，而去年同期为 NT$188.62 百万。最近与高通的合作在 AI 技术方面的产品进展增强了 Innodisk 的市场地位和超过台湾市场平均水平的收入增长潜力。</p>
<ul>
<li>我们的综合增长报告提高了 Innodisk 实现显著财务增长的可能性。</li>
<li>点击这里了解 Innodisk 的细节，查看我们的详细财务健康报告。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/c3a91485-32b6-4c06-ac57-53ee36cd1a5c/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/c3a91485-32b6-4c06-ac57-53ee36cd1a5c/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>TPEX:5289 截至 2026 年 1 月的折现现金流</p>
<h2>下一步</h2>
<ul>
<li>在这里浏览基于现金流的 259 只被低估的亚洲股票的完整清单。</li>
<li>拥有这些公司的股份？将您的持股整合到 Simply Wall St 的投资组合中，以获取通知和详细的股票报告。</li>
<li>使用 Simply Wall St 的应用程序简化您的投资策略，免费享受全球各地股票的广泛研究。</li>
</ul>
<h2>寻找新的视角？</h2>
<ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>通过稳健的分红支付者来多样化您的投资组合，以提供可靠的收入来源，以应对潜在的市场动荡。</li>
<li>通过显示强劲增长潜力的公司来充实您的投资组合，这些公司得到了分析师和管理层的乐观展望支持。</li>
</ul>
<p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们提供的评论基于历史数据和分析师预测，仅使用无偏见的方法，我们的文章不应被视为财务建议。它不构成购买或出售任何股票的推荐，也未考虑您的目标或财务状况。</strong> 我们旨在为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>

特宝生物

天齐锂业

<p>截至 2026 年 1 月，亚洲市场表现参差不齐，特别是在中国和日本。投资者正关注基于内在价值评估的被低估股票。值得关注的股票包括浙江世纪华通集团、厦门特宝生物和药明 XDC 开曼，这些股票的公允价值均显示出显著折扣。森松国际控股和天齐锂业因其增长潜力而受到关注，尽管近期面临挑战。文章强调了深入分析的重要性，并提供了对亚洲市场中各种被低估股票的见解</p>

<p>As we enter 2026, Asian markets are navigating a complex landscape marked by mixed performances in major economies like China and Japan, with slight gains in manufacturing and technology sectors amid ongoing economic uncertainties. In this environment, identifying undervalued stocks requires a keen focus on intrinsic valuation estimates, as investors seek opportunities that offer potential value amidst fluctuating market conditions.</p>
<div class="lb-trans"><p>随着我们进入 2026 年，亚洲市场正在应对一个复杂的环境，主要经济体如中国和日本的表现参差不齐，制造业和科技行业略有增长，但经济不确定性依然存在。在这种环境下，识别被低估的股票需要对内在价值估计保持敏锐的关注，因为投资者在波动的市场条件中寻求潜在价值的机会。</p>
</div><h3>Top 10 Undervalued Stocks Based On Cash Flows In Asia</h3>
<div class="lb-trans"><h3>基于现金流的亚洲十大被低估股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Current Price</strong></td>
<td><strong>Fair Value (Est)</strong></td>
<td><strong>Discount (Est)</strong></td>
</tr>
<tr>
<td>Zhejiang Century Huatong GroupLtd (SZSE:002602)</td>
<td>CN¥19.06</td>
<td>CN¥37.98</td>
<td>49.8%</td>
</tr>
<tr>
<td>Xiamen Amoytop Biotech (SHSE:688278)</td>
<td>CN¥82.07</td>
<td>CN¥161.67</td>
<td>49.2%</td>
</tr>
<tr>
<td>WuXi XDC Cayman (SEHK:2268)</td>
<td>HK$68.40</td>
<td>HK$135.71</td>
<td>49.6%</td>
</tr>
<tr>
<td>PeptiDream (TSE:4587)</td>
<td>¥1747.00</td>
<td>¥3449.68</td>
<td>49.4%</td>
</tr>
<tr>
<td>Mobvista (SEHK:1860)</td>
<td>HK$15.44</td>
<td>HK$30.63</td>
<td>49.6%</td>
</tr>
<tr>
<td>Meitu (SEHK:1357)</td>
<td>HK$7.42</td>
<td>HK$14.63</td>
<td>49.3%</td>
</tr>
<tr>
<td>CURVES HOLDINGS (TSE:7085)</td>
<td>¥792.00</td>
<td>¥1577.34</td>
<td>49.8%</td>
</tr>
<tr>
<td>Contec.Co.Ltd (KOSDAQ:A451760)</td>
<td>₩14490.00</td>
<td>₩28785.36</td>
<td>49.7%</td>
</tr>
<tr>
<td>ASE Technology Holding (TWSE:3711)</td>
<td>NT$273.50</td>
<td>NT$538.87</td>
<td>49.2%</td>
</tr>
<tr>
<td>Aidma Holdings (TSE:7373)</td>
<td>¥3160.00</td>
<td>¥6305.80</td>
<td>49.9%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>当前价格</strong></td>
<td><strong>公允价值（估计）</strong></td>
<td><strong>折扣（估计）</strong></td>
</tr>
<tr>
<td>浙江世纪华通集团有限公司 (SZSE:002602)</td>
<td>CN¥19.06</td>
<td>CN¥37.98</td>
<td>49.8%</td>
</tr>
<tr>
<td>厦门特宝生物科技 (SHSE:688278)</td>
<td>CN¥82.07</td>
<td>CN¥161.67</td>
<td>49.2%</td>
</tr>
<tr>
<td>药明 XDC 开曼 (SEHK:2268)</td>
<td>HK$68.40</td>
<td>HK$135.71</td>
<td>49.6%</td>
</tr>
<tr>
<td>PeptiDream (TSE:4587)</td>
<td>¥1747.00</td>
<td>¥3449.68</td>
<td>49.4%</td>
</tr>
<tr>
<td>Mobvista (SEHK:1860)</td>
<td>HK$15.44</td>
<td>HK$30.63</td>
<td>49.6%</td>
</tr>
<tr>
<td>美图 (SEHK:1357)</td>
<td>HK$7.42</td>
<td>HK$14.63</td>
<td>49.3%</td>
</tr>
<tr>
<td>CURVES HOLDINGS (TSE:7085)</td>
<td>¥792.00</td>
<td>¥1577.34</td>
<td>49.8%</td>
</tr>
<tr>
<td>Contec.Co.Ltd (KOSDAQ:A451760)</td>
<td>₩14490.00</td>
<td>₩28785.36</td>
<td>49.7%</td>
</tr>
<tr>
<td>ASE 科技控股 (TWSE:3711)</td>
<td>NT$273.50</td>
<td>NT$538.87</td>
<td>49.2%</td>
</tr>
<tr>
<td>Aidma Holdings (TSE:7373)</td>
<td>¥3160.00</td>
<td>¥6305.80</td>
<td>49.9%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 259 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.</p>
<div class="lb-trans"><p>点击这里查看我们基于现金流的 259 只被低估的亚洲股票的完整列表。</p>
</div><p>Here's a peek at a few of the choices from the screener.</p>
<div class="lb-trans"><p>以下是筛选器中一些选择的预览。</p>
</div><h2>Morimatsu International Holdings (SEHK:2155)</h2>
<div class="lb-trans"><h2>Morimatsu International Holdings (SEHK:2155)</h2>
</div><p><strong>Overview:</strong> Morimatsu International Holdings Company Limited is involved in the design, manufacture, installation, operation, and maintenance of core equipment and process systems for chemical reactions, biological reactions, and polymerization with a market cap of HK$12.83 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Morimatsu International Holdings Company Limited 从事化学反应、生物反应和聚合的核心设备和工艺系统的设计、制造、安装、运营和维护，市值为 HK$128.3 亿。</p>
</div><p><strong>Operations:</strong> The company generates revenue primarily from the sale of comprehensive pressure equipment, amounting to CN¥6.16 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司主要通过销售综合压力设备产生收入，金额为 CN¥61.6 亿。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 48.6%</p>
<div class="lb-trans"><p><strong>公允价值折扣估计：</strong> 48.6%</p>
</div><p>Morimatsu International Holdings appears undervalued, trading at HK$10.3 against an estimated fair value of HK$20.05, suggesting it is 48.6% below fair value based on discounted cash flow analysis. Despite significant insider selling recently and the unfortunate passing of a key board member affecting compliance with listing rules, the company shows strong potential with earnings expected to grow significantly at 23% annually, outpacing Hong Kong's market average growth rate of 12%.</p>
<div class="lb-trans"><p>Morimatsu International Holdings 似乎被低估，当前交易价格为 HK$10.3，估计公允价值为 HK$20.05，基于折现现金流分析显示其低于公允价值 48.6%。尽管最近内部人士大量抛售以及一位关键董事会成员的不幸去世影响了合规性，但该公司显示出强大的潜力，预计年收益将显著增长 23%，超过香港市场平均增长率 12%。</p>
</div><ul>
<li>In light of our recent growth report, it seems possible that Morimatsu International Holdings' financial performance will exceed current levels.</li>
<li>Unlock comprehensive insights into our analysis of Morimatsu International Holdings stock in this financial health report.</li>
</ul>
<div class="lb-trans"><ul>
<li>根据我们最近的增长报告，Morimatsu International Holdings 的财务表现似乎有可能超过当前水平。</li>
<li>在这份财务健康报告中，获取我们对 Morimatsu International Holdings 股票分析的全面见解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/743c07aa-1181-4742-99ba-a9c4f184b71b/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/743c07aa-1181-4742-99ba-a9c4f184b71b/chart/dcf?theme=light"/></p>
<p>SEHK:2155 Discounted Cash Flow as at Jan 2026</p>
<div class="lb-trans"><p>SEHK:2155 截至 2026 年 1 月的折现现金流</p>
</div><h2>Tianqi Lithium (SZSE:002466)</h2>
<div class="lb-trans"><h2>天齐锂业 (SZSE:002466)</h2>
</div><p><strong>Overview:</strong> Tianqi Lithium Corporation engages in the investment, production, processing, extraction, and sale of lithium and lithium compounds across Australia, Chile, and China with a market cap of CN¥94.40 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 天齐锂业股份有限公司从事锂及锂化合物的投资、生产、加工、提取和销售，业务遍及澳大利亚、智利和中国，市值为 CN¥944 亿。</p>
</div><p><strong>Operations:</strong> Tianqi Lithium generates revenue primarily from the production and sale of lithium, lithium concentrate, and specialty lithium compounds in Australia, Chile, and China.</p>
<div class="lb-trans"><p><strong>运营：</strong> 天齐锂业主要通过在澳大利亚、智利和中国生产和销售锂、锂浓缩物和特种锂化合物来产生收入。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 42.8%</p>
<div class="lb-trans"><p><strong>公允价值折扣估计：</strong> 42.8%</p>
</div><p>Tianqi Lithium is trading at CN¥58.62, significantly below its estimated fair value of CN¥102.5, highlighting a substantial undervaluation based on discounted cash flow analysis. Despite recent executive changes and volatile share prices, the company reported a net income turnaround for the nine months ending September 2025 and is expected to achieve profitability within three years. Revenue growth is projected to exceed China's market average, enhancing its appeal as an undervalued investment opportunity in Asia.</p>
<div class="lb-trans"><p>天齐锂业的交易价格为 CN¥58.62，显著低于其估计公允价值 CN¥102.5，基于折现现金流分析显示出显著的低估。尽管最近高管变动和股价波动，该公司在截至 2025 年 9 月的九个月内报告了净收入的扭转，预计将在三年内实现盈利。收入增长预计将超过中国市场平均水平，增强其作为亚洲被低估投资机会的吸引力。</p>
</div><ul>
<li>Insights from our recent growth report point to a promising forecast for Tianqi Lithium's business outlook.</li>
<li>Take a closer look at Tianqi Lithium's balance sheet health here in our report.</li>
</ul>
<div class="lb-trans"><ul>
<li>我们最近的增长报告提供了对天齐锂业商业前景的乐观预测。</li>
<li>在我们的报告中，仔细查看天齐锂业的资产负债表健康状况。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b0536878-1d44-4c90-bcd8-5d8b4e9d724a/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/b0536878-1d44-4c90-bcd8-5d8b4e9d724a/chart/dcf?theme=light"/></p>
<p>SZSE:002466 Discounted Cash Flow as at Jan 2026</p>
<div class="lb-trans"><p>SZSE:002466 截至 2026 年 1 月的折现现金流</p>
</div><h2>Innodisk (TPEX:5289)</h2>
<div class="lb-trans"><h2>Innodisk (TPEX:5289)</h2>
</div><p><strong>Overview:</strong> Innodisk Corporation is engaged in the research, development, manufacturing, and sale of industrial embedded storage devices across various international markets with a market cap of NT$61.50 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Innodisk Corporation 从事工业嵌入式存储设备的研究、开发、制造和销售，业务遍及多个国际市场，市值为 NT$615 亿。</p>
</div><p><strong>Operations:</strong> The company generates revenue of NT$11.68 billion from its segment focused on the research and development of various industrial memory storage devices.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司通过其专注于各种工业存储设备研发的部门产生收入，金额为 NT$116.8 亿。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 22.5%</p>
<div class="lb-trans"><p><strong>公允价值折扣估计：</strong> 22.5%</p>
</div><p>Innodisk, trading at NT$645, is valued below its estimated fair value of NT$832.02, indicating a significant undervaluation based on cash flow analysis. The company reported strong earnings growth for the third quarter of 2025, with net income reaching NT$643.04 million compared to NT$188.62 million a year ago. Recent product advancements in AI technology through collaboration with Qualcomm enhance Innodisk's market position and potential for revenue growth exceeding Taiwan's market average.</p>
<div class="lb-trans"><p>Innodisk 的交易价格为 NT$645，低于其估计公允价值 NT$832.02，基于现金流分析显示出显著的低估。该公司报告了 2025 年第三季度强劲的收益增长，净收入达到 NT$643.04 百万，而去年同期为 NT$188.62 百万。最近与高通的合作在 AI 技术方面的产品进展增强了 Innodisk 的市场地位和超过台湾市场平均水平的收入增长潜力。</p>
</div><ul>
<li>Our comprehensive growth report raises the possibility that Innodisk is poised for substantial financial growth.</li>
<li>Click here to discover the nuances of Innodisk with our detailed financial health report.</li>
</ul>
<div class="lb-trans"><ul>
<li>我们的综合增长报告提高了 Innodisk 实现显著财务增长的可能性。</li>
<li>点击这里了解 Innodisk 的细节，查看我们的详细财务健康报告。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/c3a91485-32b6-4c06-ac57-53ee36cd1a5c/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/c3a91485-32b6-4c06-ac57-53ee36cd1a5c/chart/dcf?theme=light"/></p>
<p>TPEX:5289 Discounted Cash Flow as at Jan 2026</p>
<div class="lb-trans"><p>TPEX:5289 截至 2026 年 1 月的折现现金流</p>
</div><h2>Next Steps</h2>
<div class="lb-trans"><h2>下一步</h2>
</div><ul>
<li>Navigate through the entire inventory of 259 Undervalued Asian Stocks Based On Cash Flows here.</li>
<li>Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.</li>
<li>Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里浏览基于现金流的 259 只被低估的亚洲股票的完整清单。</li>
<li>拥有这些公司的股份？将您的持股整合到 Simply Wall St 的投资组合中，以获取通知和详细的股票报告。</li>
<li>使用 Simply Wall St 的应用程序简化您的投资策略，免费享受全球各地股票的广泛研究。</li>
</ul>
</div><h2>Searching for a Fresh Perspective?</h2>
<div class="lb-trans"><h2>寻找新的视角？</h2>
</div><ul>
<li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li>
<li>Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.</li>
<li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li>
</ul>
<div class="lb-trans"><ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>通过稳健的分红支付者来多样化您的投资组合，以提供可靠的收入来源，以应对潜在的市场动荡。</li>
<li>通过显示强劲增长潜力的公司来充实您的投资组合，这些公司得到了分析师和管理层的乐观展望支持。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation.</strong> We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们提供的评论基于历史数据和分析师预测，仅使用无偏见的方法，我们的文章不应被视为财务建议。它不构成购买或出售任何股票的推荐，也未考虑您的目标或财务状况。</strong> 我们旨在为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div>

亚洲价值股精选用于 2026 年 1 月的内在估值预测